Press release 2010-06-22
New distribution in China
C-RAD AB with its three fully owned subsidiaries are all active in the field of
radiation therapy. The company has signed a distribution agreement for the fast
growing market in China.
C-RAD has signed an agreement with the Chinese company Beijing KANGLIDA Trading
Corporation to distribute the C-RAD program on the Chinese market. KANGLIDA has
a long experience in radiation therapy and excellent relationships with some of
the most important clinics on the Chinese market. . C-RAD's laser scanner system
Sentinel will for this market be an important system to improve accuracy and
increase efficiency in patient positioning and motion detection both for use in
conventional conformal radiation therapy and for the advanced techniques. New
functionality for respiratory gating will in 2010 be introduced
Erik Hedlund, CEO, C-RAD AB:
"AS a part of the C-RAD focused marketing strategy, we are very pleased to have
signed a distribution agreement with Beijing KANGLIDA for the Chinese market.
Relationships with the owners of KANGLIDA are established since middle of the
90´s.
China is a demanding market. As a first step the approval process for the C-RAD
Sentinel system will be started."
For further information:
Erik Hedlund, CEO C-RAD AB, Telefon 018 - 66 69 31, E-post erik.hedlund@c-rad.se
About C-RAD AB
C-RAD develops new and innovative solutions for the use in advanced radiation
therapy. The company group of C-RAD offers products and solutions for patient
positioning, tumor localization and radiation treatment systems. End users are
radiation therapy clinics worldwide. All product development is conducted in
three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD
Innovation AB. C-RAD Imaging AB is located in Östersund while the other
companies are located in Uppsala. Numbers of employees are currently 19 people.
The activities in C-RAD AB originate from research and development at the
Karolinska Institutet in Solna. Sales of the company's first product, the C-RAD
SentinelTM, started in 2007. Cooperation agreements have been signed with the
Swedish company Elekta and the Belgian company IBA. C-RAD is represented by
distributors specialized in radiation therapy on major markets. C-RAD AB is
since March 2010 listed at Nasdaq Omx First North Premier.
